Jennifer Hopwood
About Jennifer Hopwood
Jennifer Hopwood is the Vice President of WW Hematology - Multiple Myeloma at Bristol Myers Squibb, with extensive experience in global strategic marketing and new product development.
Current Role at Bristol Myers Squibb
Jennifer Hopwood currently serves as the Vice President for Worldwide Hematology, focused specifically on Multiple Myeloma at Bristol Myers Squibb in Summit, New Jersey. Additionally, she holds the title of Vice President of Global Marketing for Multiple Myeloma at the same company.
Previous Role at Celgene
Jennifer worked at Celgene as the Executive Director of US Marketing for Multiple Myeloma from 2013 to 2016. During her three-year tenure in Summit, NJ, she was involved in strategic marketing initiatives aimed at advancing the company's footprint in hematology.
Executive Roles at Johnson & Johnson
Between 2001 and 2012, Jennifer Hopwood held multiple executive roles within Johnson & Johnson. She was the Executive Director of Global Strategic Marketing for Cardiology at Cordis/J&J in Bridgewater, NJ, from 2007 to 2012. Prior to that, Jennifer served as the Executive Director for Strategic Planning at the J&J Corporate Medical Devices & Diagnostics Group between 2004 and 2007. She started her tenure at J&J as the Vice President of Sales & Marketing for Drug Delivery/Neuro at Codman/J&J from 2001 to 2003.
Education Background
Jennifer Hopwood studied Marketing at Hofstra University, where she also completed one year of her MBA studies prior to relocating for a job promotion. She holds a Bachelor of Business Administration (BBA).
Skills and Expertise
Jennifer Hopwood is an expert in global strategic marketing, new product development, and market development. Her skill set includes strategic planning, portfolio management, and providing competitive market insights. She has a strong track record in launching, branding, and positioning new products, and is adept at making strategic choices and opportunity assessments. Known for her ability to lead business units through various stages—including startup, growth, and maturity—Jennifer excels in turning concepts into reality and delivering results in ambiguous situations. She is also recognized for developing high-performing teams and pioneering new roles to set industry standards.